Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy

Despite the importance of accurate disease definitions for effective management and treatment decisions, there is currently no consensus on what constitutes oligometastatic non–small‐cell lung cancer (NSCLC). Predominant patterns of initial progressive disease (PD) after first‐line systemic therapy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Sci
Hauptverfasser: Miyawaki, Taichi, Wakuda, Kazushige, Kenmotsu, Hirotsugu, Miyawaki, Eriko, Mamesaya, Nobuaki, Kobayashi, Haruki, Omori, Shota, Ono, Akira, Naito, Tateaki, Murakami, Haruyasu, Notsu, Akifumi, Mori, Keita, Harada, Hideyuki, Endo, Masahiro, Ohde, Yasuhisa, Takahashi, Kazuhisa, Takahashi, Toshiaki
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Clinical Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780027/
https://ncbi.nlm.nih.gov/pubmed/33098119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14707
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge